1973
DOI: 10.1001/archderm.107.4.580
|View full text |Cite
|
Sign up to set email alerts
|

Verrucae vulgaris rejection. A preliminary study of contact dermatitis and cellular immunity response

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
9
0

Year Published

1982
1982
2013
2013

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…4 This phenomenon has been reported with other contact sensitizers such as dinitrochlorobenzene, so is not peculiar to DPCP. 5 Spontaneous resolution would of course also explain resolution of untreated warts.…”
Section: Discussionmentioning
confidence: 99%
“…4 This phenomenon has been reported with other contact sensitizers such as dinitrochlorobenzene, so is not peculiar to DPCP. 5 Spontaneous resolution would of course also explain resolution of untreated warts.…”
Section: Discussionmentioning
confidence: 99%
“…Follow-up treatment consists of intermittent applfcations of the antigen to the wart surface to achieve a small, controlled area of contact dermatitis at the base of the wart, which may stimulate a specfflc or nonspecfflc delayed hypersensitivity reaction. 13 This method has been used effectively and safely in treating warts, despite some theoretical concerns regarding the mutagenicity of dtnftrochlorobenzene in the Ames test. 1 I would recommend referral of the patient to a dermatologist for immunotherapy unless thorough training has been completed and the method Is used frequently.…”
Section: Intralesjonal Injections Of Bleomycin-mentioning
confidence: 99%
“…5 Contact immunotherapy induces type IV delayedtype hypersensitivity reaction, and has been used for the treatment of various types of warts. [6][7][8][9] However, the effectiveness of contact immunotherapy differs from patient to patient. Such a variation in treatment results is allegedly related to the immunological characteristics of each patient.…”
Section: Introductionmentioning
confidence: 99%